J Korean Med Sci.  2017 Oct;32(10):1588-1594. 10.3346/jkms.2017.32.10.1588.

Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?

• Omma A
• Sandikci S
• Kücüksahin O
• Alisik M
• Erel O

• KMID: 2400429
• DOI: http://doi.org/10.3346/jkms.2017.32.10.1588

Abstract

Familial Mediterranean fever (FMF) is a chronic autoinflammatory condition characterized by fever attacks and recurrent polyserositis. Subclinical inflammation that persists during attack-free periods can result in oxidative stress (OS) damage. Thiol groups bind to reactive oxygen radicals and protect cells and tissues from OS damage. The aim of this study was to investigate the relationship between thiol-disulfide balance and colchicine resistance in FMF patients during an attack or attack-free period. A newly developed spectrophotometric method was used to measure native thiol (NT) and disulfide (DS) levels in FMF patients and an age-sex matched group of healthy controls. NT and DS levels were compared in FMF patients 1) with vs. without colchicine resistance; and 2) during an attack (FMF-AP) vs. attack-free period (FMF-AFP). A total of 118 FMF patients and 60 healthy controls were studied. NT (P < 0.001) and total thiol (TT) (P < 0.001) levels in FMF patients were significantly lower compared to healthy controls. NT (P = 0.030) and TT (P = 0.010) levels of FMF-AP patients were significantly lower than that of FMF-AFP patients. FMF-AP patients had significantly higher DS levels than FMF-AFP patients (P = 0.039). Compared to FMF patients without colchicine resistance, elevated levels of DS (P = 0.019) but not NT (P = 0.620) and TT (P = 0.718) were found in those with colchicine resistance. Thiol-disulfide homeostasis is altered in FMF patients during an attack period and this imbalance may be associated with colchicine resistance.

Keyword

Familial Mediterranean Fever; Thiol; Disulfide; Colchicine Resistance; Attack

MeSH Terms

Colchicine*
Familial Mediterranean Fever*
Fever
Homeostasis
Humans
Inflammation
Methods
Oxidative Stress
Reactive Oxygen Species
Colchicine
Reactive Oxygen Species

Reference

1. Gershoni-Baruch R, Brik R, Shinawi M, Livneh A. The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet. 2002; 10:145–149. PMID: 11938447.

2. Koo KY, Park SJ, Wang JY, Shin JI, Jeong HJ, Lim BJ, Lee JS. The first case of familial Mediterranean fever associated with renal amyloidosis in Korea. Yonsei Med J. 2012; 53:454–458. PMID: 22318840.

3. Kim ML, Chae JJ, Park YH, De Nardo D, Stirzaker RA, Ko HJ, Tye H, Cengia L, DiRago L, Metcalf D, et al. Aberrant actin depolymerization triggers the pyrin inflammasome and autoinflammatory disease that is dependent on IL-18, not IL-1β. J Exp Med. 2015; 212:927–938. PMID: 26008898.

4. Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, Feigenbaum L, Katz SI, Kastner DL. Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. Immunity. 2011; 34:755–768. PMID: 21600797.

5. Ben-Zvi I, Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol. 2011; 7:105–112. PMID: 21060333.

6. Korkmaz C, Ozdogan H, Kasapçopur O, Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis. 2002; 61:79–81. PMID: 11779767.

7. Karaguezyan KG, Haroutjunian VM, Mamiconyan RS, Hakobian GS, Nazaretian EE, Hovsepyan LM, Hoveyan GA, Gevorkian EM, Hovakimyan SS, Zakarian AE, et al. Evidence of oxidative stress in erythrocyte phospholipid composition in the pathogenesis of familial Mediterranean fever (periodical disease). J Clin Pathol. 1996; 49:453–455. PMID: 8763256.

8. Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem J. 2007; 401:1–11. PMID: 17150040.

9. Yilmaz S, Ozgu-Erdinc AS, Demirtas C, Ozturk G, Erkaya S, Uygur D. The oxidative stress index increases among patients with hyperemesis gravidarum but not in normal pregnancies. Redox Rep. 2015; 20:97–102. PMID: 25327635.

10. Cohen JM, Kramer MS, Platt RW, Basso O, Evans RW, Kahn SR. The association between maternal antioxidant levels in midpregnancy and preeclampsia. Am J Obstet Gynecol. 2015; 213:695.e1–695.e13. PMID: 26215330.

11. Erer B, Demirkaya E, Ozen S, Kallinich T. What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review. Rheumatol Int. 2016; 36:483–487. PMID: 26712372.

12. Majeed HA, Barakat M. Familial Mediterranean fever (recurrent hereditary polyserositis) in children: analysis of 88 cases. Eur J Pediatr. 1989; 148:636–641. PMID: 2663516.

13. Zemer D, Livneh A, Danon YL, Pras M, Sohar E. Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum. 1991; 34:973–977. PMID: 1859491.

14. Ben-Chetrit E, Aamar S. About colchicine compliance, resistance and virulence. Clin Exp Rheumatol. 2009; 27:S1–S3.

15. Ozen S, Kone-Paut I, Gül A. Colchicine resistance and intolerance in familial Mediterranean fever: definition, causes, and alternative treatments. Semin Arthritis Rheum. Forthcoming. 2017.

16. Hentgen V, Grateau G, Kone-Paut I, Livneh A, Padeh S, Rozenbaum M, Amselem S, Gershoni-Baruch R, Touitou I, Ben-Chetrit E. Evidence-based recommendations for the practical management of familial Mediterranean fever. Semin Arthritis Rheum. 2013; 43:387–391. PMID: 23742958.

17. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014; 47:326–332. PMID: 25304913.

18. Şahin A, Erten Ş, Altunoğlu A, Işıkoğlu S, Neşelioğlu S, Ergin M, Atalay HV, Erel Ö. Comparison of serum oxidant and antioxidant parameters in familial Mediterranean fever patients (FMF) with attack free period. Acta Reumatol Port. 2014; 39:316–321. PMID: 25007287.

19. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997; 40:1879–1885. PMID: 9336425.

20. Biswas S, Chida AS, Rahman I. Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem Pharmacol. 2006; 71:551–564. PMID: 16337153.

21. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010; 48:749–762. PMID: 20045723.

22. Ates I, Ozkayar N, Inan B, Yilmaz FM, Topcuoglu C, Neselioglu S, Erel O, Dede F, Yilmaz N. Dynamic thiol/disulphide homeostasis in patients with newly diagnosed primary hypertension. J Am Soc Hypertens. 2016; 10:159–166. PMID: 26725016.

23. Ates I, Kaplan M, Inan B, Alisik M, Erel O, Yilmaz N, Guler S. How does thiol/disulfide homeostasis change in prediabetic patients? Diabetes Res Clin Pract. 2015; 110:166–171. PMID: 26421363.

24. Kundi H, Ates I, Kiziltunc E, Cetin M, Cicekcioglu H, Neselioglu S, Erel O, Ornek E. A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis. Am J Emerg Med. 2015; 33:1567–1571. PMID: 26143314.

25. Gao C, Li T, Liu J, Guo Q, Tian L. Endothelial functioning and hemodynamic parameters in rats with subclinical hypothyroid and the effects of thyroxine replacement. PLoS One. 2015; 10:e0131776. PMID: 26158620.

26. Yucel A, Sanhal CY, Daglar K, Kara O, Uygur D, Erel O. Thiol/disulphide homeostasis in pregnant women with familial Mediterranean fever. Redox Rep. 2016; 21:287–291. PMID: 27077456.

27. Musabak U, Sengul A, Oktenli C, Pay S, Yesilova Z, Kenar L, Sanisoglu SY, Inal A, Tuzun A, Erdil A, et al. Does immune activation continue during an attack-free period in familial Mediterranean fever? Clin Exp Immunol. 2004; 138:526–533. PMID: 15544632.

28. Yildirim K, Uzkeser H, Keles M, Karatay S, Kiziltunc A, Kaya MD, Yildirim A. Relationship between serum interleukin-1beta levels and acute phase response proteins in patients with familial Mediterranean fever. Biochem Med (Zagreb). 2012; 22:109–113. PMID: 22384525.

29. Lagnoux D, Darbre T, Schmitz ML, Reymond JL. Inhibition of mitosis by glycopeptide dendrimer conjugates of colchicine. Chemistry. 2005; 11:3941–3950. PMID: 15861378.

30. Kirkali G, Tunca M, Genc S, Jaruga P, Dizdaroglu M. Oxidative DNA damage in polymorphonuclear leukocytes of patients with familial Mediterranean fever. Free Radic Biol Med. 2008; 44:386–393. PMID: 17967429.

31. Karakurt Arıtürk Ö, Üreten K, Sarı M, Yazıhan N, Ermiş E, Ergüder İ. Relationship of paraoxonase-1, malondialdehyde and mean platelet volume with markers of atherosclerosis in familial Mediterranean fever: an observational study. Anadolu Kardiyol Derg. 2013; 13:357–362. PMID: 23531873.

32. Savran Y, Sari I, Kozaci DL, Gunay N, Onen F, Akar S. Increased levels of macrophage migration inhibitory factor in patients with familial Mediterranean fever. Int J Med Sci. 2013; 10:836–839. PMID: 23794947.

33. Migita K, Izumi Y, Fujikawa K, Agematsu K, Masumoto J, Jiuchi Y, Kozuru H, Nonaka F, Shimizu T, Nakamura T, et al. Dysregulated mature IL-1β production in familial Mediterranean fever. Rheumatology (Oxford). 2015; 54:660–665. PMID: 25240611.

34. Ediz L, Ozkol H, Tekeoglu I, Tuluce Y, Gulcu E, Koyuncu I. Increased oxidative stress in patients with familial Mediterranean fever during attack period. Afr Health Sci. 2011; (11):Suppl 1. S6–S13. PMID: 22135646.

35. Guzel S, Andican G, Seven A, Aslan M, Bolayirli M, Guzel EC, Hamuryudan V. Acute phase response and oxidative stress status in familial Mediterranean fever (FMF). Mod Rheumatol. 2012; 22:431–437. PMID: 21947799.

36. Ben-Chetrit E, Bergmann S, Sood R. Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases: a possible new outlook through microarray analysis. Rheumatology (Oxford). 2006; 45:274–282. PMID: 16188942.

37. Gasparyan AY, Ayvazyan L, Yessirkepov M, Kitas GD. Colchicine as an anti-inflammatory and cardioprotective agent. Expert Opin Drug Metab Toxicol. 2015; 11:1781–1794. PMID: 26239119.

38. Erden M, Ediz L, Hız Ö, Tuluce Y, Ozkol H, Toprak M, Demirdag F. Effect of colchicine on total antioxidant capacity, antioxidant enzymes and oxidative stress markers in patients with knee osteoarthritis. Int J Clin Med. 2012; 3:377–382.

39. Chia EW, Grainger R, Harper JL. Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine. Br J Pharmacol. 2008; 153:1288–1295. PMID: 18264123.

40. Solomon F, Monard D, Rentsch M. Letter: stabilization of colchicine-binding activity of neuroblastoma. J Mol Biol. 1973; 78:569–573. PMID: 4754846.